4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-18-012008
President and CEO sold 19,578 shares at $29.43 ($576,141)
- President and CEO acquired 19,578 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McCarthy Sean A. President and CEO | 2018-03-01 | Option exercise | +10,516 | $1.57 | $16,562 | 15,159 | D: show line 1 in the form |
| McCarthy Sean A. President and CEO | 2018-03-01 | Option exercise | +9,000 | $1.13 | $10,205 | 24,159 | D: show line 2 in the form |
| McCarthy Sean A. President and CEO | 2018-03-01 | Option exercise | +62 | $0.95 | $59 | 24,221 | D: show line 3 in the form |
| McCarthy Sean A. President and CEO | 2018-03-01 | Sale | −19,578 | $29.43 | $576,141 | 4,643 | D: show line 4 in the form |
| Open-market sales · 19,578 sh · avg $29.43 · $576,141 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McCarthy Sean A. President and CEO | 2018-03-01 | Option exercise · Stock Option (Right to Buy) | −10,516 | 194,804 | D: show line 5 in the form | ||
| McCarthy Sean A. President and CEO | 2018-03-01 | Option exercise · Stock Option (Right to Buy) | −9,000 | 328,143 | D: show line 6 in the form | ||
| McCarthy Sean A. President and CEO | 2018-03-01 | Option exercise · Stock Option (Right to Buy) | −62 | 66,752 | D: show line 7 in the form |
Loading xslF345X03/doc1.xml…